ADAR1 Capital Management »

Amylyx Pharmaceuticals shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $748k 231k 3.24
2024-06-30 $223k 117k 1.90
2024-03-31 $411k 145k 2.84
2023-12-31 $1.8M 121k 14.72

More positions owned by ADAR1 Capital Management

Cytokinetics Com New (CYTK)
Protagonist Therapeutics (PTGX)
Bridgebio Pharma (BBIO)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Ascendis Pharma A/s Sponsored Adr (ASND)
Zura Bio Class A Ord Shs (ZURA)
Zai Lab Adr (ZLAB)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Aa Mission Acquisition Corp Ord Shs Cl A (AAM)
Mineralys Therapeutics (MLYS)
Syndax Pharmaceuticals (SNDX)

View all positions for ADAR1 Capital Management

Top funds holding Amylyx Pharmaceuticals

TCG Crossover Management
Vanguard Group
BlackRock
Citadel Advisors
Perceptive Advisors
Alyeska Investment Group
683 Capital Management
Almitas Capital
Acadian Asset Management
Standard Life Aberdeen
Goldman Sachs Group
Nantahala Capital Management
Farallon Capital Management
Bank of America Corporation
Connor, Clark & Lunn Investment Management

View all funds holding Amylyx Pharmaceuticals